Table 1 Descriptive data of the studied groups according to gender, associated diseases, and etiology of liver disease
Cirrhosis (n = 150) | Non-cirrhotic (n = 150) | Test of sig. | P | |||
|---|---|---|---|---|---|---|
No. | % | No. | % | |||
Gender | ||||||
Male | 90 | 60.0 | 50 | 33.3 | χ2 = 21.429* | < 0.001* |
Female | 60 | 40.0 | 100 | 66.7 | ||
Age (years) | ||||||
Min.–max. | 25.0–87.0 | 19.0–87.0 | t = 3.928* | < 0.001* | ||
Mean ± SD. | 60.01 ± 12.37 | 52.37 ± 20.33 | ||||
Median | 60.0 | 52.0 | ||||
Co-morbidity | ||||||
No | 86 | 57.3 | 95 | 63.3 | 1.128 | 0.288 |
DM | 15 | 10.0 | 24 | 16.0 | 2.387 | 0.122 |
HTN | 17 | 11.3 | 38 | 25.3 | 9.818* | 0.002* |
IHD | 6 | 4.0 | 21 | 14.0 | 9.158* | 0.002* |
Thyrotoxicosis | 2 | 1.3 | 4 | 2.7 | 0.680 | FEp = 0.684 |
Hypothyroidism | 2 | 1.3 | 0 | 0.0 | 2.013 | FEp = 0.498 |
Asthmatic | 2 | 1.3 | 2 | 1.3 | 0.000 | FEp = 1.000 |
Thalassemia | 0 | 0.0 | 1 | 0.7 | 1.003 | 1.000 |
Cause of cirrhosis | ||||||
Non-viral | 28 | 18.7 | ||||
HCV | 94 | 62.7 | ||||
HBV | 28 | 18.7 | ||||